Overall rank by patents
#2,794
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Qiagen Gmbh
USPTO PatentsView assignee record — 138 granted patents across 31 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
138
Total patents granted
31
CPC technology areas
20.3
Avg claims per patent
-23%
5-year filing velocity
The verdict
Qiagen holds 138 US patents across 31 technology areas — rank #2,794 of 50,000 tracked assignees.
- #2,794
- of 50,000 US assignees by volume
- Top 11%
- by Innovation Score (51.9/100)
- 20.3
- avg claims per patent
- -23%
- filing velocity, last 5 yrs
Portfolio overview
QIAGEN GmbH has been granted 138 US utility patents between 2015 and 2025, placing QIAGEN GmbH at rank #2,794 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.3 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a Foreign Corporation, QIAGEN GmbH is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 78 in the 2015–2019 window — a -23% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. QIAGEN GmbH's 20.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 31 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark QIAGEN GmbH against peers pursuing similar technology classes.
How does QIAGEN compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Qiagen ◀ 138
QIAGEN GmbH
138 patents
What this shows QIAGEN holds 138 patents — placing it at rank #2,794 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
QIAGEN's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 20 | 14.5% |
| 2016 | 16 | 11.6% |
| 2017 | 15 | 10.9% |
| 2018 | 13 | 9.4% |
| 2019 | 14 | 10.1% |
| 2020 | 22 | 15.9% |
| 2021 | 13 | 9.4% |
| 2022 | 10 | 7.2% |
| 2023 | 5 | 3.6% |
| 2024 | 7 | 5.1% |
| 2025 | 3 | 2.2% |
Which technologies does QIAGEN GmbH patent most?
B01J— CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 4
Top 15 of 31 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Declining
Frequently Asked Questions
How many patents does QIAGEN GmbH hold?
QIAGEN GmbH holds 138 US granted patents filed between 2015 and 2025, spanning 31 technology areas.
What is QIAGEN GmbH's Innovation Score?
QIAGEN GmbH has an Innovation Score of 51.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does QIAGEN GmbH focus on?
QIAGEN GmbH's top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 78 patents. The company has filed patents in 31 CPC subclasses total.
Is QIAGEN GmbH's patent filing rate increasing or decreasing?
QIAGEN GmbH's recent filing velocity is -23% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for QIAGEN GmbH's patents?
QIAGEN GmbH's patents average 20.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the QIAGEN GmbH patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
How to use this portfolio
Qiagen's 138 grants land it in the top 11% by Innovation Score — but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance — Qiagen ranks #2,794 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12Q — see who else leads that technology area. C12Q leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
C12Q technology
QIAGEN GmbH's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where QIAGEN GmbH ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov
